Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis

NCT03343639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Psoriasis

Interventions

DRUG: 5 mg Serlopitant Tablets
DRUG: Matching Placebo Tablets

Sponsor

Vyne Therapeutics Inc.